Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning

[1]  R. Little Regression with Missing X's: A Review , 2011 .

[2]  Alan Horwich,et al.  Testicular germ-cell cancer , 2006, The Lancet.

[3]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[4]  J Schleicher,et al.  Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer , 2002, British Journal of Cancer.

[5]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[6]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[7]  H S Koops,et al.  Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era , 2001, Cancer.

[8]  C. Meisner,et al.  Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  J. Habbema,et al.  Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. , 2000, Statistics in medicine.

[10]  J. Richie,et al.  The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985–1996 , 1999, Cancer.

[11]  C. Meisner,et al.  First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[13]  R. Motzer,et al.  Risk assessment for metastatic testis cancer. , 1998, The Urologic clinics of North America.

[14]  P. Wilkinson,et al.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Loh,et al.  Tree-structured proportional hazards regression modeling. , 1994, Biometrics.

[16]  D. Clayton,et al.  Statistical Models in Epidemiology , 1993 .

[17]  M. LeBlanc,et al.  Relative risk trees for censored survival data. , 1992, Biometrics.

[18]  P. Grambsch,et al.  Martingale-based residuals for survival models , 1990 .

[19]  M R Segal,et al.  A comparison of estimated proportional hazards models and regression trees. , 1989, Statistics in medicine.

[20]  N. Geller,et al.  Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Harrell,et al.  Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.

[22]  Douglas G Altman,et al.  Developing a prognostic model in the presence of missing data: an ovarian cancer case study. , 2003, Journal of clinical epidemiology.

[23]  A. Horwich,et al.  The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  N. Geller,et al.  Assessment of risk in metastatic testis carcinoma: impact on treatment. , 1991, Urologia internationalis.